BANNED: Obama to Save You From Evil Donut Sprinkles!

-By Warner Todd Huston

All hail President Obama, our most benevolent dictator on high. He is so wonderful to we lowly, stupid citizens that next year his FDA is going to save us all from the evils of donut sprinkles with a ban on transfats that will have an effect the nefarious product.

Yes, our great half white father in Washington is really only concerned about our wellbeing, isn’t he?

As Mike Flynn reported last week, early next year Obama’s Food and Drug Administration is set to firm up its new rules governing the evil, monstrous, highly dangerous sprinkles. And to save us from our own too-stupid selves, Obama is planning to ban the tiny, multicolored decorations.
Continue reading


BANNED: Obama to Save You From Evil Donut Sprinkles!”


Banning BPA Will Kill People – The BPA File, Part Six

-By Alan Caruba

The lies being told about Bisphenol-A, BPA, via the print and broadcast media, and via the Internet are a destructive tsunami intended to ban its use. If successful, people will die.

In previous parts of this series on BPA, I have identified environmental organizations and public relations firms that have worked as sponsors and/or purveyors of systematic falsehoods about BPA.

The inescapable conclusion is that there is an intricate matrix of comparable groups behind a global fraud that reeks of the same pathology and methodology as the disgraced and debunked “global warming” hoax. But the results of a successful BPA hoax could have deadly consequences.

BPA has been in use for more than a half century and as such, it is among the most tested substances in use today. It is used to line the insides of metal containers and to make shatterproof safety plastics. Unlike what the junk science merchants would have us believe, BPA is not a carcinogen, it is not mutagenic and it’s not an ‘endocrine disruptor.’

Stated simply, BPA improves human health and safety.
Continue reading


Banning BPA Will Kill People – The BPA File, Part Six”


Food Fascism Lays Groundwork For Additional Control

-By Frederick Meekins

Wonder what the food fascists advocating dietary asceticism scarfed down as children. As anyone that has sat through an evangelistic missionary testimonial knows, those griping the loudest about your errant ways are usually the ones that could make a sailor blush before they came to religion.

A Chicago school’s policy of controlling what students eat is an example of the threat posed to human liberty by public education. Sad thing is many private educators are just as eager to usurp parental authority. Compounding that, if schools are religious, they’ll then compile lengthy theological justifications why you are not a “good Christian” if you don’t have a smile plastered across your face regarding the handed-down decree.

If babykillers insist that the government should keep its laws off the body of women wanting abortions, who in the name of Hades are these civil servants to tell anyone what they can or cannot eat for lunch? Students forced to eat food they don’t want should toss it in the trash in defiance or preferably hold mass puke rallies and refuse to clean up their own regurgitation.
Continue reading


Food Fascism Lays Groundwork For Additional Control”


Scaring Mothers and All Others – The BPA File, Part Four

-By Alan Caruba

In a revealing article in the April issue of The Atlantic, “Beyond BPA: Could ‘BPA-Free’ Products Be Just as Unsafe?” the effort to scare American consumers and others around the world comes full circle. In essence, the people and organizations behind campaigns to ban bisphenol-A (BPA) and anything made from plastic exist to frighten everyone about everything.

From the snake oil salesmen who pitched their phony medicines in the days of the early West to today’s purveyors of fear about a wide range of chemicals that protect health and extend life, the key element remains the same; they lie to enrich themselves.

As John Entine wrote in an article, “Scared to Death”, “When it comes to stories on so-called toxic substances, the public discourse seems infected by a malady worse than microscopic residues: chemophobia.”
Continue reading


Scaring Mothers and All Others – The BPA File, Part Four”


The Big BPA Lie – The BPA File, Part Three

-By Alan Caruba

When I began this series about bisphenol-A, BPA, I instituted a Google Alert for Internet posts that mentioned it. From January through March it generated a report each day filled with notifications of newspaper, magazine, and Internet posts all denouncing BPA has a hazardous chemical that threatened the health of everyone from infants to adults.

More than one thousand posts were reported. Virtually all spread false information.

Such things do not happen by accident. They are the result of a concerted effort to defame BPA and they are indicative of a massive public relations effort. Serendipitously, on March 2nd the National Review published an article by Jon Entire, “Don’t Rush to Ban Chemicals” that revealed how public opinion is manipulated by the use of dubious “scientific studies” and the way most people, unschooled in science, do not realize that “one part per billion” of any substance poses no risk at all.
Continue reading


The Big BPA Lie – The BPA File, Part Three”


Demonizing Bisphenol-A: The BPA File, Part One

-By Alan Caruba

In July 2010 I wrote a commentary about Bisphenol-A, more commonly called BPA. It is a chemical that has been in wide, safe use for over 50 years, but has come under a horrendous and unrelenting attack by a variety of specious environmental and consumer groups.

Out of curiosity mostly, I initiated a Google Alert earlier this month to inform me whenever BPA was mentioned in a news story on the Web. Within three weeks I received 20 alerts, almost one a day, and each contained notifications on 15 – 25 different article references. That’s just nuts!

Why are Americans being bombarded in the space of a single month with more than 400 articles in magazines, newspapers, and on the Internet that are designed to frighten them into thinking that a good, safe thing is a bad thing?
Continue reading


Demonizing Bisphenol-A: The BPA File, Part One”


Pseudoephedrine Restrictions Nothing To Sneeze At

-By Frederick Meekins

Each winter without fail, the flu sends millions to the local pharmacy in search of some kind of relief. However, it won’t be this pesky virus that will give you a headache and make your stomach churn.

In order to purchase pseudoephedrine, consumers must now produce a photo ID (something that is apparently an outrage to require illegal aliens to do when accused of a crime) with these details added into a computer database tracking how much and often you purchase this perfectly legal substance. It is claimed that this procedure is necessary as a result of the meth epidemic sweeping across the country since pseudoephedrine is an ingredient used to make this drug.

While methamphetamine might be illegal, pseudoephedrine is not and is available over the counter in smaller doses. If the nanny state wants to restrict access to this substance, why not make it unavailable in its entirety without a prescription or enact an outright prohibition all together.
Continue reading


Pseudoephedrine Restrictions Nothing To Sneeze At”


FDA: Dec. 17, Countdown to a Death Panel for Breast Cancer Drug Avastin

-By Warner Todd Huston

In a few days the Food and Drug Administration (FDA) is expected to release its final decision on whether or not 17,000 women across the country will have the same access to the breast cancer drug Avastin that they now have. Several congressmen, thousands of doctors and patients, and many small government activists stand against this perceived example of Obamacare-like rationing.

As I reported last week, with this Avastin situation five Congressmen have become alerted to the threat that government is instituting cost-based rationing of healthcare and have become alarmed at the effects that will have on the sick. It seems that this FDA decision will set the table for the rationing war to come under Obamacare unless that legislation is repealed or inhibited.

Avastin is, admittedly, an expensive drug. But are we ready for government to decide if your lifesaving medicines are “too expensive” to be allowed for use? Is that the cost-based road down which we wish to travel? And how far down that road do we go? How much cost-cutting do we want government to indulge where it concerns our health? And should government even have that role in the first place?

These are questions that the Avastin decision evokes.
Continue reading


FDA: Dec. 17, Countdown to a Death Panel for Breast Cancer Drug Avastin”


FDA Set To Cut Off 17,000 Women Annually From Lifesaving Drug

-By Warner Todd Huston

Obama’s Food and Drug Administration (FDA) is due to take up the case of Avastin, a cancer drug that successfully treats some 17,000 women annually. With a coming December 17 decision, the FDA seems poised to take this drug away from these patients quite despite the fact that their doctors find the drug effective.

The most dangerous period of time in Washington D.C. is that time we call the lame duck session (I call it the zombie congress; dead men walking). It is that time when those elected officials that are about to be ingloriously shipped off home for the last time due to losing election results make a mad scramble to grab for as much as they can get.

In the case of regulatory agencies like the FDA the lame duck session is not treated in exactly the same manner, but it is sure that when congress is about to have its majority party change over with the president’s party on the losing side of the switch, regulatory agencies often try to push through favored policies before the new congress is seated and before that new congress is in a position to put any pressure on those agencies to prevent them from pushing the president’s agenda.
Continue reading


FDA Set To Cut Off 17,000 Women Annually From Lifesaving Drug”


During Breast Cancer Month Obama’s FDA Ponders Delisting Cancer Drug

-By Warner Todd Huston

So you have Avastin, a drug used to treat breast cancer that has a record of extending the lives of sufferers for at least five and a half months, and it’s October, the month declared Breast Cancer Awareness Month. If you are the Obama Federal Drug Administration, what do you do? Apparently you look to delist the drug.

This October the FDA is trying to decide to delist Avastin because in keeping with its new Obamacare rationing impulses it has decided Avastin costs too much.

In September the FDA announced that it was going to delay its final decision perhaps until December on whether or not to take Avastin off the market for breast cancer patients. There was no clear indication of just when the decision would be made, but conveniently the decision certainly will be delayed until after the coming elections. As a result President Obama won’t have to worry about taking a drug away from breast cancer patients in the midst of an election cycle.

The calculation of skipping past the elections is hard to ignore.
Continue reading


During Breast Cancer Month Obama’s FDA Ponders Delisting Cancer Drug”


Feds Deciding When Healthcare Science Costs Too Much To Save Lives

-By Warner Todd Huston

If anyone wants a current example of what is looming ahead for medical science at the hands of Obamacare, the Avastin controversy is a perfect one. The Food and Drug Administration (FDA) wants to de-list the cancer drug Avastin one reason being that it is a drug too expensive for government to fund. It is scary to think that the federal government can summarily dismiss cancer drugs merely because of expense, but that is what happens when government starts counting the beans. It becomes an issue of cost instead of effectiveness.

There were other reasons that the FDA wants to dump Avastin, but cost was one of them. One of those that sat in judgment of Avastin admitted that cost was a factor in the decision to delegitimize the treatment. Natalie Compagni Portis, a member of one of the panels that the FDA convened to investigate the drug, said, “We aren’t supposed to talk about cost, but that’s another issue.”
Continue reading


Feds Deciding When Healthcare Science Costs Too Much To Save Lives”